4/2
03:02 am
insm
Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts [Yahoo! Finance]
Low
Report
Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts [Yahoo! Finance]
3/25
08:27 am
insm
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference [Yahoo! Finance]
Low
Report
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference [Yahoo! Finance]
3/25
08:00 am
insm
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
Low
Report
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
3/20
10:43 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Bank of America Co. from $92.00 to $96.00. They now have a "buy" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Bank of America Co. from $92.00 to $96.00. They now have a "buy" rating on the stock.
3/19
10:45 am
insm
Insmed Incorporated (NASDAQ: INSM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
3/12
11:57 pm
insm
Tracking Baker Brothers Portfolio - Q4 2024 Update [Seeking Alpha]
Medium
Report
Tracking Baker Brothers Portfolio - Q4 2024 Update [Seeking Alpha]
3/10
08:00 am
insm
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/6
06:31 pm
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $105.00 to $110.00. They now have a "buy" rating on the stock.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $105.00 to $110.00. They now have a "buy" rating on the stock.
2/25
10:32 am
insm
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $101.00 price target on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $101.00 price target on the stock.
2/25
07:15 am
insm
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $100.00 price target on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $100.00 price target on the stock.
2/24
11:23 am
insm
International Markets and Insmed (INSM): A Deep Dive for Investors [Yahoo! Finance]
Low
Report
International Markets and Insmed (INSM): A Deep Dive for Investors [Yahoo! Finance]
2/24
08:00 am
insm
Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
Low
Report
Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
2/21
12:41 pm
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Truist Financial Co. from $105.00 to $108.00. They now have a "buy" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Truist Financial Co. from $105.00 to $108.00. They now have a "buy" rating on the stock.
2/21
09:53 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target lowered by analysts at Stifel Nicolaus from $97.00 to $96.00. They now have a "buy" rating on the stock.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) had its price target lowered by analysts at Stifel Nicolaus from $97.00 to $96.00. They now have a "buy" rating on the stock.
2/21
08:47 am
insm
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
2/20
07:21 am
insm
Insmed beats top-line and bottom-line estimates; initiates FY25 outlook [Seeking Alpha]
Low
Report
Insmed beats top-line and bottom-line estimates; initiates FY25 outlook [Seeking Alpha]
2/20
07:17 am
insm
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/20
07:00 am
insm
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update
Low
Report
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update
2/19
10:17 am
insm
Will Insmed Incorporated's (INSM) New Drugs be Able to Peak Sales? [Yahoo! Finance]
Low
Report
Will Insmed Incorporated's (INSM) New Drugs be Able to Peak Sales? [Yahoo! Finance]
2/19
10:11 am
insm
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
2/19
09:07 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $107.00. They now have an "overweight" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $107.00. They now have an "overweight" rating on the stock.
2/11
10:59 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $88.00 to $97.00. They now have a "buy" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $88.00 to $97.00. They now have a "buy" rating on the stock.
2/11
08:00 am
insm
Insmed To Present at March 2025 Investor Conferences
Low
Report
Insmed To Present at March 2025 Investor Conferences
2/10
08:00 am
insm
Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025
Medium
Report
Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025
2/7
04:26 pm
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $83.00 to $92.00. They now have an "overweight" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $83.00 to $92.00. They now have an "overweight" rating on the stock.